Your Notifications
All done, no notifications
Dr. Prof. Fabio Ciceri

Dr. Prof. Fabio Ciceri

Hematologist ·
, milan, Italy

32 Years of experience ·
Languages Spoken: English, Italian

Book a video consultation with Prof. Fabio Ciceri for Hematologist, from USD 503. Receive a signed report within 24 hours or a full refund if unavailable.

Specialises in:

Acute leukemiaAcute myeloid leukemia (AML)Other acute leukemias, depending on the specific diagnosisAggressive lymphomasSelected high-risk hematological malignancies

About Dr. Prof. Fabio Ciceri

  • Prof. Fabio Ciceri is a haematologist specialising in blood cancers, hematopoietic stem cell transplantation, and advanced cellular and gene therapies.
  • According to the supplied biography, he heads the Haematology and Bone Marrow Transplant and Oncohematology Units.
  • Since 2018, he has been a Full Professor of Haematology at Vita-Salute San Raffaele University in Milan, Italy, where he also directs the Haematology Specialisation School.
  • He graduated in Medicine and Surgery from the University of Pavia and completed specialisations in Rheumatology at the University of Ferrara and Haematology at the University of Milan.
  • His clinical interests include acute leukaemia, aggressive lymphomas, myeloproliferative neoplasms, and anaemias.
  • He has extensive experience in autologous and allogeneic hematopoietic stem cell transplantation using different donor sources, including matched family donors, unrelated donors, and haploidentical family donors.
  • His transplantation expertise extends to selected blood cancers, solid tumours, and non-malignant conditions, including autoimmune, neuroinflammatory, and haemoglobin-related disorders.
  • His research has contributed to the development of haploidentical transplantation as a treatment option for selected patients with high-risk haematological malignancies.
  • Since 1996, he has participated as a Principal Investigator in clinical development programmes involving advanced cell therapy, gene therapy, and regenerative medicine for oncological and non-oncological diseases.
  • His research includes cellular therapies using the HSV-TK suicide gene to control donor lymphocytes after transplantation and gene therapy programmes for primary immunodeficiencies, metabolic diseases, and beta-thalassemia.

Conditions treated by Prof. Fabio CICERI

  • Acute leukemia
  • Acute myeloid leukemia (AML)
  • Other acute leukemias, depending on the specific diagnosis
  • Aggressive lymphomas
  • Selected high-risk hematological malignancies
  • Myeloproliferative neoplasms

Area of Interest

  • Acute leukemia and acute myeloid leukemia
  • Aggressive lymphomas
  • Myeloproliferative neoplasms
  • Hematopoietic stem cell transplantation
  • Autologous stem cell transplantation
  • Allogeneic stem cell transplantation
  • Haploidentical transplantation

Qualification

  • Degree in Medicine and Surgery - University of Pavia, Italy, 1989.
  • Specialization in Rheumatology - University of Ferrara, Italy, 1995.
  • Specialization in Hematology - University of Milan, Italy, 2001.

Work Experiences

  • Head of the Hematology and Bone Marrow Transplant Units - As stated in the supplied biography.
  • Head of the Oncohematology Unit - As stated in the supplied biography.
  • Full Professor of Hematology - Vita-Salute San Raffaele University, Milan, Italy, since 2018.
  • Director, Hematology Specialization School - Vita-Salute San Raffaele University, Milan, Italy.
  • Principal Investigator in Clinical Development Programmes - Advanced cell therapy, gene therapy, and regenerative medicine programmes since 1996, according to the supplied biography.

Memberships (9)

  • Italian Society of Hematology (SIE)
  • Italian Bone Marrow Transplant Group (GITMO)
  • Lombardy Hematological Network (REL)
  • Italian Group of Adult Hematological Diseases (GIMEMA)
  • European Society for Blood and Marrow Transplantation (EBMT)
  • European Hematology Association (EHA)
  • International Network of Cancer Treatment and Research (INCTR)
  • International Cardio-Oncology Society (ICOS)
  • European Technology Platform for Nanomedicine (ETPN)

Ready to Speak with Prof. Fabio Ciceri?

Book a secure video consultation for expert Transplant Surgeon care.

What to Expect in Your Consultation

Upload Your Medical Reports

Upload MRI/CT scans, laboratory reports, prescriptions, and previous medical records. Supported formats: PDF, JPEG, and DICOM.

30-Min Video Consultation

Consult the Doctor in your preferred language. A family member or caregiver is welcome to join.

Medical Opinion Within 24 Hours

Receive a signed medical opinion with diagnosis, treatment recommendations, and next steps in a downloadable PDF.

Care Coordination (Optional)

If needed, our team can assist with a second opinion, hospital appointments, or medical travel arrangements.

Procedures Performed

Bone Marrow Transplant

Frequently Asked Questions

Prof. Fabio CICERI is available to teleconsult on the MediGence platform.

The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s questions and the doctor's medical recommendations.

We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the availability of the doctor and the patient.

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

The option to share your medical records is available between steps in the form provided on the website.

Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, with assistance from our case managers.

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Hematologist

A hematologist is a medical specialist who diagnoses and treats disorders of the blood, bone marrow, and lymphatic system. These include anemia, blood clotting disorders, leukemia, lymphoma, and other blood cancers. Treatment depends on the specific condition and its severity.

A bone marrow or hematopoietic stem cell transplant may be used to treat selected blood cancers, bone marrow disorders, immune deficiencies, and some inherited blood or metabolic conditions. Not every patient is eligible. The transplant team evaluates the diagnosis, disease status, previous treatments, donor options, organ function, and treatment risks.

Gene therapy aims to treat a disease by introducing, modifying, or correcting genetic material in cells. Some approaches use a patient's own blood-forming stem cells that have been modified in a laboratory. Availability, eligibility, long-term monitoring, and risks vary by the specific therapy and disease.

Cell therapy uses cells to treat or modify a disease process. Gene therapy involves changing or introducing genetic material to achieve a therapeutic effect and may use modified cells as the delivery method. Some treatments combine both approaches; their indications, risks, and availability vary.

Pre-transplant assessment may include blood tests, bone marrow examination, disease-specific molecular tests, infection screening, heart and lung assessments, kidney and liver function tests, and HLA typing for donor matching. The exact tests depend on the patient's diagnosis and the proposed transplant approach.

Explore Telemedicine Specialists

Please Enquire

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Not Sure About Your Treatment Plan? Get a Second Opinion

Get your medical reports reviewed by experienced doctors to help you make a confident treatment decision, all online within 48 hours.